5-MEMBERED HETEROCYCLES FOR THE TREATMENT OF HUMAN DISEASES INVOLVING MODULATORS OF SELECTINS

摘要

Compounds of formulas (1), (2) and (3) are disclosed, where at least one and no more than two of R<1>, R<2>, R<3>, R<4> or R<5> are as defined in Group 1. In said formulas R<1> is typically a moiety containing a terminal carboxylic acid group such as phenoxy acetic acid, R<2> is typically a hydrophobic moiety such as functionalized alkyl chain or a functionalized aryl group, and R<3> is typically a functionalized aryl group, and they are within the scope of this invention. These compounds exhibit inhibitory activity against the Selectins and are indicated in the treatment of human diseases involving Selectins.